


Shared by @DrFrankLipman ↗
Shared by @Medscape ↗

Alzheimer’s disease is driven by pathological brain changes that progressively impair memory and cognition, with current treatment options being limited. Advances in early, biomarker-based diagnosis and amyloid-targeting and other disease-modifying approa
A new study describes a gene therapy strategy that uses the brain's own glymphatic transport system to distribute engineered viral vectors throughout the brain.


Shared by @Medscape ↗
Shared by @JAMA_current ↗
theconversation.com14d ago

Shared by @DocAmen ↗
Shared by @Medscape ↗

Shared by @Medscape ↗

Shared by @DocAmen ↗
Shared by @newscientist ↗
Shared by @Medscape ↗